Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021.

Curtis, Stephanie J, Shah, Abdul W, Ratu, Ana, Wilson, Donald J, Hill, Philip C, Hulcome, Phil, Gaylard, Cathy, Faktaufon, Daniel, Cabemaiwai, Talica and Rabukawaqa, Isireli (2023) Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021. Emerging Infectious Diseases, 29 (1).

Abstract

During November–December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8–70 years of age were 95.5% (95% CI 93.4%–97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.

Documents
4164:1987
[thumbnail of Rapid SARS-CoV-2.pdf]
Preview
Rapid SARS-CoV-2.pdf - Published Version

Download (270kB) | Preview
Information
Library
Statistics

Downloads

Downloads per month over past year

View Item